What's new

Human medicines European public assessment report (EPAR): Jyseleca, filgotinib, Date of authorisation: 24/09/2020, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Jyseleca, filgotinib, Date of authorisation: 24/09/2020, Revision: 14, Status: Authorised

Jun 10, 2025 - 13:45
 0
Human medicines European public assessment report (EPAR): Jyseleca, filgotinib, Date of authorisation: 24/09/2020, Revision: 14, Status: Authorised
Human medicines European public assessment report (EPAR): Jyseleca, filgotinib, Date of authorisation: 24/09/2020, Revision: 14, Status: Authorised
Read More

Tags:

Previous Article

2024 annual report of the European Medicines Agency

Next Article

EMEA-003393-PIP01-23

Related Posts

Orphan designation: Humanised IGg1 monoclonal antibody targeting human transferrin receptor conjugated to human iduronate-2-sulfatase Treatment of mucopolysaccharidosis type II (Hunter's syndrome), 26/02/2019 Positive

Orphan designation: Humanised IGg1 monoclonal antibody ...

Jun 10, 2025  0

Human medicines European public assessment report (EPAR): Instanyl, fentanyl, Date of authorisation: 20/07/2009, Revision: 39, Status: Authorised

Human medicines European public assessment report (EPAR...

May 21, 2025  0

Withdrawn application: Amyvid, 26/02/2025

Withdrawn application: Amyvid, 26/02/2025

May 28, 2025  0